Tim Coughlin

(Mr. Timothy Coughlin CPA)

Currently holds positions in Fate Therapeutics Inc, Retrophin Inc and aTyr Pharma Inc

Positions
Position Company Period
Independent Director Fate Therapeutics Inc Aug. 1, 2013 -
Independent Director Retrophin Inc March 31, 2015 -
Independent Director aTyr Pharma Inc April 7, 2017 -
Chief Financial Officer, Vice President Neurocrine Biosciences Inc Sept. 1, 2006 - Dec. 31, 2016
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-06-06 2022-06-03
S Sale
1,439 -2.4%
22.81
32,824 USD 		1,439 -2.4% 22.81 32,824 USD
2017-02-08 2017-02-06
PS Planned sale
963 -0.7%
43.14
41,544 USD 		963 -0.7% 43.14 41,544 USD
2017-02-06 2017-02-03
PS Planned sale
1,500 -1.1%
42.55
63,825 USD 		1,500 -1.1% 42.55 63,825 USD
2017-01-18 2017-01-17
PS Planned sale
1,750 -1.3%
40.65
71,138 USD 		1,750 -1.3% 40.65 71,138 USD
2016-02-04 2016-02-03
PS Planned sale
1,500 -1.1%
38.06
57,090 USD 		1,500 -1.1% 38.06 57,090 USD
2016-01-21 2016-01-19
PS Planned sale
1,750 -1.3%
46.69
81,708 USD 		1,750 -1.3% 46.69 81,708 USD
2016-01-13 2016-01-11
PS Planned sale
1,750 -1.3%
44.25
77,438 USD 		1,750 -1.3% 44.25 77,438 USD